We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

26 hedge funds and large institutions have $45.3M invested in Urovant Sciences Ltd. in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

24% less funds holding

Funds holding: 34 → 26 (-8)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

47% less capital invested

Capital invested by funds: $86.3M → $45.3M (-$41M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
26
Holders Change
-8
Holders Change %
-23.53%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
7
Reduced
9
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$1.97M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.55M
3
PA
Perceptive Advisors
New York
+$1.48M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$840K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.21M
2
ACM
Asymmetry Capital Management
California
-$1.9M
3
Norges Bank
Norges Bank
Norway
-$1.5M
4
BlackRock
BlackRock
New York
-$1.36M
5
HI
HBK Investments
Texas
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$9.13M +$1.55M +170,000 +14%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$8.78M +$1.21M +132,701 +11%
SCM
3
Sio Capital Management
New York
$5.32M +$1.97M +216,406 +37%
EAM
4
Eventide Asset Management
Massachusetts
$4.41M +$675K +74,184 +12%
PA
5
Perceptive Advisors
New York
$3.92M +$1.48M +162,700 +35%
PWAM
6
Park West Asset Management
California
$3.13M -$455K -50,000 -10%
Millennium Management
7
Millennium Management
New York
$2.66M -$829K -91,114 -18%
GTC
8
Ghost Tree Capital
New York
$1.98M – – –
BlackRock
9
BlackRock
New York
$1.52M -$1.36M -150,000 -39%
SFM
10
Sphera Funds Management
Israel
$1.41M +$455K +50,000 +30%
SB
11
Samsara BioCapital
California
$1.04M +$1.43M +157,480 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$608K +$840K +92,324 New
KCM
13
Kornitzer Capital Management
Kansas
$337K -$217K -23,900 -32%
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$291K +$402K +44,192 New
HCMT
15
Highland Capital Management (Texas)
Texas
$198K -$256K -28,100 -48%
LCM
16
Laurion Capital Management
New York
$173K -$672K -73,795 -74%
Man Group
17
Man Group
United Kingdom
$128K -$51.2K -5,631 -23%
WMSA
18
Weiss Multi-Strategy Advisers
New York
$99K +$37.7K +4,146 +38%
Two Sigma Investments
19
Two Sigma Investments
New York
$72K +$99.8K +10,968 New
Barclays
20
Barclays
United Kingdom
$37K +$51.2K +5,627 New
Deutsche Bank
21
Deutsche Bank
Germany
$22K +$30.8K +3,390 New
TRCT
22
Tower Research Capital (TRC)
New York
$20K +$27.1K +2,980 New
PHK
23
Point72 Hong Kong
Hong Kong
$5K -$105K -11,576 -94%
CSS
24
Cubist Systematic Strategies
Connecticut
$3K +$4.07K +447 New
PCM
25
Prelude Capital Management
New York
$1K -$303K -33,244 -99%
1
2

UROV Hedge Fund Activity: Q4 2018 in Review

26 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q4 2018, worth a combined $45.3M — down 47% from $86.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of UROV and 9 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Sio Capital Management, adding an estimated $1.97M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.21M sold.

  • 26 institutional investors held Urovant Sciences Ltd. (UROV) as of Q4 2018, down from 34 in Q3 2018.
  • Funds reported $45.3M of Urovant Sciences Ltd. stock for Q4 2018, down 47% quarter-over-quarter.
  • 9 funds opened new Urovant Sciences Ltd. positions in Q4 2018 and 16 closed out, a net change of -7 holders.
  • The largest Urovant Sciences Ltd. buyer in Q4 2018 was Sio Capital Management, an estimated $1.97M added.
  • The largest Urovant Sciences Ltd. seller in Q4 2018 was Citadel Advisors, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2018.